美国匹兹堡大学医学院的科学家们最近在人类血液中发现了一类以前未被识别的抗体。这种免疫系统蛋白似乎能中和多种形式的流感病毒，这为开发靶向季节性病毒且能提供广泛保护性疫苗提供了关键线索。相关论文最近发表在12月21日出版的《公共科学图书馆·生物》杂志上。
这项研究为流感病毒的治疗和疫苗开发带来了重大的突破。以前的抗体只能识别和中和特定的流感病毒，而新型抗体则能够识别和中和多种流感病毒，这为疫苗研究提供了新的方向。
科学家们表示，这种新型抗体具有广泛的应用前景，可以用于治疗和预防季节性流感病毒感染。虽然目前该抗体还处于早期研究阶段，但已经显示出巨大的潜力。
该研究的发现引起了广泛关注，许多科学家和医学专家认为这是一项非常重要的研究，可以为我们提供更好的季节性流感疫苗。
英文标题：
New Antibodies Can Battle Multiple Influenza Viruses, Perhaps for Vaccine Development
关键词：new antibodies, influenza viruses, vaccine development
新闻内容：
Scientists at the University of Pittsburgh Medical School in the United States recently discovered a new class of antibodies in human blood that can neutralize multiple forms of influenza virus. This immune protein appears to be able to target and neutralize seasonal flu viruses, providing key insights into developing targeted and widely protective vaccines. The study, published in the journal Public Library of Science 生物 on December 21, 2022, is generating significant attention from the scientific community and medical experts.
This discovery holds great promise for the treatment and prevention of seasonal flu virus infections.以前的抗体只能识别和中和特定的流感病毒，而新型抗体则能够识别和中和多种流感病毒， providing a new direction for vaccine research.
Scientists say that this new antibody has broad applications and can be used for both treatment and prevention of seasonal flu virus infections. Although the study is still in the early stages of research, it has already shown great potential.
The finding has attracted widespread attention from the scientific and medical communities, with many experts believing it will lead to the development of better seasonal flu vaccines.
【来源】http://www.chinanews.com/life/2023/12-25/10134533.shtml
Views: 4